EPISODE · Aug 30, 2024 · 10 MIN
Insights from the FLOW Trial | ESC 2024
from JACC This Week
Neha J. Pagidipati, MD, FACC, JACC Associate Editor, and Richard Pratley, MD, discuss insights from the FLOW trial – revealing that semaglutide reduced heart failure events and cardiovascular death by approximately 27%, both in patients with and without prior heart failure.
Embed this episode
NOW PLAYING
Insights from the FLOW Trial | ESC 2024
0:00
10:24
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JACC This Week?
This episode is 10 minutes long.
When was this JACC This Week episode published?
This episode was published on August 30, 2024.
Can I download this JACC This Week episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!